Search by Drug Name or NDC

    NDC 62332-0204-71 ITRACONAZOLE 100 mg/1 Details

    ITRACONAZOLE 100 mg/1

    ITRACONAZOLE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is ITRACONAZOLE.

    Product Information

    NDC 62332-0204
    Product ID 62332-204_11cfe913-bd14-4c13-8352-647135ee2fbe
    Associated GPIs 11407035000120
    GCN Sequence Number 016949
    GCN Sequence Number Description itraconazole CAPSULE 100 MG ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 49101
    HICL Sequence Number 006503
    HICL Sequence Number Description ITRACONAZOLE
    Brand/Generic Generic
    Proprietary Name ITRACONAZOLE
    Proprietary Name Suffix n/a
    Non-Proprietary Name itraconazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name ITRACONAZOLE
    Labeler Name Alembic Pharmaceuticals Inc.
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206741
    Listing Certified Through 2024-12-31

    Package

    NDC 62332-0204-71 (62332020471)

    NDC Package Code 62332-204-71
    Billing NDC 62332020471
    Package 500 CAPSULE in 1 BOTTLE (62332-204-71)
    Marketing Start Date 2016-12-16
    NDC Exclude Flag N
    Pricing Information N/A